Delta opioid peptide (D-Ala2, D-Leu5)-enkephalin (DADLE) mitigates myocardial ischemia-reperfusion injury by inhibiting the TRAF6/NF-κB/NLRP3 pathway

Articles in Press

Document Type : Original Article

Authors

1 1 Department of Cardiology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China

2 Department of Neurology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China

3 Department of Pathology, Shanghai Fourth People’s Hospital Affiliated to Tongji University, Shanghai, China

10.22038/ijbms.2025.87794.18971

Abstract

Objective(s): This study aimed to assess the dose-dependent effect of DADLE and to explore its relationship with the TRAF6/NF-κB/NLRP3 pathway.
Materials and Methods: After 45 min of ischemia, reperfusion was sustained for 24 hr in mice to establish the myocardial infarction model. DADLE was administered at doses of 0.25, 0.5, or 1 mg/kg to this model. TTC-Evans Blue double staining, HE staining, and Masson staining were conducted to evaluate myocardial injury. TUNEL staining was used to detect apoptosis. Western blotting and immunofluorescence staining were applied to measure levels of TRAF6, NF-κB p65, NLRP3, caspase-1, pro-caspase-1, and ASC. ELISA assays were used to assess TNF-α and IL-1β levels. 
Results: DADLE at all three doses lessened the infarcted area compared with the PBS control. DADLE at 0.5 mg/kg was more efficacious than 0.25 and 1 mg/kg in reducing the infarcted size, pathological scores, and fibrosis. DADLE effectively reduced the number of apoptotic cells as shown by the TUNEL assay. Levels of TRAF6, NF-κB p65, ASC, NLRP3, caspase-1, and pro-caspase-1 proteins were increased after ischemia-reperfusion (I/R) but were reversed by DADLE. Immunofluorescence staining results for NF-κB and NLRP3 demonstrated similar changes. ELISA assays showed that TNF-α and IL-1β concentrations were increased in the model and reversed by DADLE. 
Conclusion: DADLE can significantly ameliorate myocardia ischemia-reperfusion injury (MIRI), with the dosage of 0.5 mg/kg presenting the greatest benefit. DADLE may exert its protective effects by activating the TRAF6/NF-κB/NLRP3 signaling pathway.

Keywords

Main Subjects

References

1. Wang X, Chen T, Chen S, Zhang J, Cai L, Liu C, et al. STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation. Signal Transduct Target Ther 2025;10:136-152.
2. Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: A report of US and Global data from the American Heart Association. Circulation 2024;149:e347-e913.
3. Chen DX, Feng YY, Wang HY, Lu CH, Liu DZ, Gong C, et al. Metrnl ameliorates myocardial ischemia-reperfusion injury by activating AMPK-mediated M2 macrophage polarization. Mol Med 2025;31:98-113.
4. Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab 2024;35:219-234.
5. Spodnick MB, McElderry SC, Diaz MR. Opioid receptor signaling throughout ontogeny: Shaping neural and behavioral trajectories. Neurosci Biobehav Rev 2025;170:106033.
6. Chen Y, Zhang H, Jiang L, Cai W, Kuang J, Geng Y, et al. DADLE promotes motor function recovery by inhibiting cytosolic phospholipase A(2) mediated lysosomal membrane permeabilization after spinal cord injury. Br J Pharmacol 2024;181:712-734.
7. Liu L, Sun Y, Wang Y, Xin J, Chen W. (D-Ala2, D-Leu5)-enkephalin (DADLE) provides protection against myocardial ischemia reperfusion injury by inhibiting Wnt/β-Catenin pathway. BMC Cardiovasc Disord 2024;24:115-125.
8. Xu Y, Chen R, Zhi F, Sheng S, Khiati L, Yang Y, et al. δ-opioid receptor, microglia and neuroinflammation. Aging Dis 2023;14:778-793.
9. Zhang S, Yan F, Luan F, Chai Y, Li N, Wang YW, et al. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury. Phytomedicine 2024;129:155649.
10. Fu D, Liu H, Zhu J, Xu H, Yao J. (D-Ala(2), D-Leu(5)) enkephalin inhibits TLR4/NF-κB signaling pathway and protects rat brains against focal ischemia-reperfusion injury. Mediators Inflamm 2021;2021:6661620.
11. Li B, Yang WW, Yao BC, Chen QL, Zhao LL, Song YQ, et al. Liriodendrin alleviates myocardial ischemiareperfusion injury via partially attenuating apoptosis, inflammation and mitochondria damage in rats. Int J Mol Med 2025;55:65-76.
12. Zi C, Ma X, Zheng M, Zhu Y. VDAC1-NF-κB/p65-mediated S100A16 contributes to myocardial ischemia/reperfusion injury by regulating oxidative stress and inflammatory response via calmodulin/CaMKK2/AMPK pathway. Eur J Pharmacol 2025;987:177158.
13. Li J, Wei JJ, Wu CH, Zou T, Zhao H, Huo TQ, et al. Epimedin A inhibits the PI3K/AKT/NF-κB signalling axis and osteoclast differentiation by negatively regulating TRAF6 expression. Mol Med 2024;30:125-136.
14. Passos PRC, Vieira AA, de Melo RPM, Pinheiro Filho RF, Sampaio LG, Santos H, et al. Clustering based on innate immunity reveals differential dysregulation based on disease severity in myelodysplastic neoplasms. Hematol Oncol 2025;43:e70104.
15. Chen XZ, Xu HF, Zhao XM, Li FH, Ren JH, Zhou LY, et al. PYRCR alleviates myocardial ischemia/reperfusion injury in mice via inhibiting DRG2-mediated cardiomyocyte pyroptosis. Acta Pharmacol Sin 2025; doi: 10.1038/s41401-025-01604-9.
16. Xu G, Sun X, An J, Sun F, Zhang C, Williams JP. Ozone protects from myocardial ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome. Eur J Pharmacol 2025;997:177631.
17. Pandey A, Li Z, Gautam M, Ghosh A, Man SM. Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis. Immunol Rev 2025;329:e13406.
18. Yang Y, Zhu Y, Liu C, Cheng J, He F. Taohong Siwu decoction reduces acute myocardial ischemia-reperfusion injury by promoting autophagy to inhibit pyroptosis. J Ethnopharmacol 2024; 321:117515.
19. Li Y, Wang X, Meng X, Xia C, Yang C, Wang J, et al. Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect ischemia-reperfusion injury. Mol Med 2024;30:273-284.
20. Ye B, Xu D, Zhong L, Wang Y, Wang W, Xu H, et al. Ubiquitin-specific protease 25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes. Clin Transl Med 2025;15:e70243.
21. Liu Y, Li X, Sun T, Li T, Li Q. Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications. Eur J Pharmacol 2024;971:176464.
22. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 2010;107:1445-1453.
23. Wang D, Wang J, Yang L, Wang X, Huang S. Dexmedetomidine plays a protective role in sepsis-associated myocardial injury by repressing PRMT5-mediated ferroptosis. Toxicol Res (Camb) 2025;14:tfaf010.
24. Theisen MM, Schlottmann S, August C, Herzog C, Theilmeier G, Maas M, et al. Detection and distribution of opioid peptide receptors in porcine myocardial tissue. Pharmacol Res 2014;84:45-49.
25. Peng J, Sarkar S, Chang SL. Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 2012;124:223-228.
26. Popov SV, Mukhomedzyanov AV, Maslov LN, Naryzhnaya NV, Kurbatov BK, Prasad NR, et al. The infarct-reducing effect of the δ(2) opioid receptor agonist deltorphin II: The molecular mechanism. Membranes (Basel) 2023;13: 63-73.
27. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000;36:2296-2302.
28. Funcke S, Werner TR, Hein M, Ulmer BM, Hansen A, Eschenhagen T, et al. Effects of the delta opioid receptor agonist DADLE in a novel hypoxia-reoxygenation model on human and rat-engineered heart tissue: A pilot study. Biomolecules 2020;10:1309-1322.
29. Kunecki M, Płazak W, Roleder T, Biernat J, Oleksy T, Podolec P, et al. ‘Opioidergic postconditioning’ of heart muscle during ischemia/reperfusion injury. Cardiol J 2017;24:419-26.
30. Zhang Y, Irwin MG, Lu Y, Mei B, Zuo YM, Chen ZW, et al. Intracerebroventricular administration of morphine confers remote cardioprotection--role of opioid receptors and calmodulin. Eur J Pharmacol 2011;656:74-80.
31. Surendra H, Diaz RJ, Harvey K, Tropak M, Callahan J, Hinek A, et al. Interaction of δ and κ opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning. J Mol Cell Cardiol 2013;60:142-150.
32. Lendeckel U, Müller C, Röcken C, Laube B, Täger M, Huth C, et al. Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 2005;28 Suppl 1:S275-S279.
33. Karlsson LO, Bergh N, Li L, Bissessar E, Bobrova I, Gross GJ, et al. Dose-dependent cardioprotection of enkephalin analogue Eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion. Eur J Pharmacol 2012;674:378-383.
34. Dong X, Jiang J, Lin Z, Wen R, Zou L, Luo T, et al. Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization. Phytomedicine 2022;101:154093.
35. Tian K, Song L, Liu L, Lai T, Liu W. Rutin protects myocardial ischemia-reperfusion injury via the NF-κB/NLRP3/pyroptosis pathway. ACS Omega 2025;10:21777-21785.
36. Ghanta SN, Kattamuri LPV, Odueke A, Mehta JL. Molecular insights into ischemia-reperfusion injury in coronary artery disease: mechanisms and therapeutic implications: A comprehensive review. Antioxidants (Basel) 2025;14: 213-228.
37. Liu X, Shui G, Wang Y, Chen T, Zhang P, Liu L, et al. Remimazolam alleviates myocardial ischemia/reperfusion injury and inflammation via inhibition of the NLRP3/IL1β pathway in mice. Int J Mol Med 2025;55: 57-68.
38. Liu H, Huang R, Zhuo Z, Zhang X, Wu L, Guo Z, et al. Activation of kappa opioid receptor suppresses post-traumatic osteoarthritis via sequestering STAT3 on the plasma membrane. Cell Commun Signal 2024;22:335-348.
39. Zhang D, Wang Q, Qiu X, Chen Y, Yang X, Guan Y. Remifentanil protects heart from myocardial ischaemia/reperfusion (I/R) injury via miR-206-3p/TLR4/NF-κB signalling axis. J Pharm Pharmacol 2022;74:282-291.
40. Chang W, Chen X, Yang Y, Deng Y, Dong L, Wu H. Geomagnetic activity affects animal myocardial ischemia/reperfusion injury: An experimental-simulated study. Int J Biometeorol 2024;68:731-742.
41. Wu PX, Yang WP, Feng T, Zhang J, Zhu GQ, Du XG, et al. African swine fever virus I177L induces host inflammatory responses by facilitating the TRAF6-TAK1 axis and NLRP3 inflammasome assembly. J Virol 2025;99:e0208024.
42. Zhao Z, Li Y, Chi F, Ma L, Li Y, Hou Z, et al. Sevoflurane postconditioning ameliorates cerebral ischemia-reperfusion injury in rats via TLR4/MyD88/TRAF6 signaling pathway. Aging (Albany NY) 2022;14:10153-10170.
43. Meng WT, Zhu J, Wang YC, Shao CL, Li XY, Lu PP, et al. Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-κB signaling pathway after myocardial ischemia-reperfusion injury. J Nanobiotechnology 2024;22:382-400.
44. Dawuti A, Sun S, Wang R, Gong D, Liu R, Kong D, et al. Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathways. Biomed Pharmacother 2023;168:115837.
45. Bhardwaj A, Panepinto MC, Ueberheide B, Neel BG. A mechanism for hypoxia-induced inflammatory cell death in cancer. Nature 2025;637:470-477.
46. Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell 2024;187:235-256.
47. Hua F, Li JY, Zhang M, Zhou P, Wang L, Ling TJ, et al. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction. J Food Biochem 2022;46:e14305.
48. Zhang L, Zhao S, Wang Y. Diannexin alleviates myocardial ischemia-reperfusion injury by orchestrating cardiomyocyte oxidative damage, macrophage polarization and fibrotic process by TLR4-NF-kB-mediated inactivation of NLRP3 inflammasome. Int Immunopharmacol 2024;130:111668.
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 15 December 2025

Files

Share

How to cite

Statistics